Assistant Professor
Matthew LeBlanc PhD, RN is an Assistant Professor at UNC School of Nursing. Dr. LeBlanc received his BSN at MGH Institute of Health Professions in 2010 and has spent much of his clinical career caring for oncology patients in both the inpatient and outpatient settings. He received his PhD from Duke University School of Nursing in 2021.Dr. LeBlanc then joined UNC as a post doctoral fellow in the Cancer Care Quality Training Program in 2021 and joined faculty at the UNC School of Nursing in 2022.
Dr. LeBlanc’s research has focused on understanding the symptom burden and health-related quality of life challenges of patients with multiple myeloma. More recent work has explored treatment access, with a focus on understanding treatment access disparities. Dr. LeBlanc’s work has been supported by the National Cancer Institute, the National Institute of Nursing Research, the American Cancer Society, and the UNC Cancer Information and Population Health Resource New Investigator Program.
James B. Duke Fellow
UNC Cancer Information and Population Health Resource New Investigator
International Myeloma Young Investigator Award
American Society for Hematology Advocacy Leadership Institute
LeBlanc MR, LeBlanc TW, Yang Q, McLaughlin J, Irish K, Smith SK. A Mobile App to Support Self-Management in Patients with Multiple Myeloma or Chronic Lymphocytic Leukemia: Pilot Randomized Controlled Trial. JMIR cancer. 2023;9:e44533. doi:10.2196/44533
Reeder-Hayes, KE, Jackson, B, Baggett, CD, Kuo, T, Gaddy, J, LeBlanc MR, Green, L, Wheeler, SB. Race, Geography and Risk of Breast Cancer Treatment Delays: A Population-Based Study 2004-2015. Cancer (in-press)
Jensen CE, Vohra SN, Nyrop KA, et al. Physical Function, Psychosocial Status, and Symptom Burden Among Adults with Plasma Cell Disorders and Associations with Quality of Life. The Oncologist. 2022. DOI: 10.1093/oncolo/oyac079
LeBlanc MR, Leak Bryant, A, LeBlanc TW, Yang Q, Sellars E, Costa Chase C, Smith SK. A cross-sectional observational study of health-related quality of life in adults with multiple myeloma. Support Care Cancer. 2022. DOI 10.1007/s00520-022-06943-5
Smith SK, Somers TJ, Kuhn E, et al. A SMART approach to optimizing delivery of an mHealth intervention among cancer survivors with posttraumatic stress symptoms. Contemp Clin Trials. 2021. 110:106569.
LeBlanc MR, Zimmerman S, LeBlanc TW, Bryant AL, Hudson KE, Smith SK. Persistent fatigue among long-term non-Hodgkin lymphoma survivors. Leuk Lymphoma. 2021:1-9. DOI: 10.1080/10428194.2021.1984450
LeBlanc MR, LeBlanc TW, Leak Bryant A, Pollak KI, Bailey DE, Smith SK. A Qualitative Study of the Experiences of Living with Multiple Myeloma. Oncol Nurs Forum. 2021; 48(2):151-160.
Noonan D, LeBlanc M, Conley C, et al. Quality of Life and Impact of Cancer: Differences in Rural and Nonrural Non-Hodgkin’s Lymphoma Survivors. J Rural Health. 2020;36(4):536-542. DOI: 0.1111/jrh.12420
Smith SK, Westbrook K, MacDermott K, Amarasekara S, LeBlanc M, Pan W. Four Conversations: A Randomized Controlled Trial of an Online, Personalized Coping and Decision Aid for Metastatic Breast Cancer Patients. J Palliat Med. 2020;23(3):353-358. DOI: 10.1089/jpm.2019.0234
LeBlanc MR, Hirschey R, Leak Bryant A, LeBlanc TW, Smith SK. How are patient-reported outcomes and symptoms being measured in adults with relapsed/refractory multiple myeloma? A systematic review. Qual Life Res. 2020; 29(6):1419-1431. DOI: 10.1007/s11136-019-02392-6